Trexquant Investment’s Rhythm Pharmaceuticals RYTM Stock Holding History

Trexquant Investment’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.25M	Buy	+56,248	New	+$5.09M	0.04%	629
2025 Q4	–	Sell	-37,161	Closed	-$3.75M	–	1883
2025 Q3	$3.75M	Buy	37,161 +30,078	+425%	+$2.79M	0.04%	655
2025 Q2	$448K	Sell	7,083 -31,641	-82%	-$1.94M	0.01%	1289
2025 Q1	$2.05M	Buy	38,724 +30,926	+397%	+$1.72M	0.02%	863
2024 Q4	$437K	Buy	+7,798	New	+$431K	0.01%	1318
2023 Q4	–	Sell	-24,514	Closed	-$562K	–	1734
2023 Q3	$562K	Buy	+24,514	New	+$549K	0.01%	969
2021 Q2	–	Sell	-11,535	Closed	-$245K	–	1451
2021 Q1	$245K	Buy	+11,535	New	+$335K	0.02%	864
2018 Q3	–	Sell	-12,950	Closed	-$405K	–	1163
2018 Q2	$405K	Buy	+12,950	New	+$354K	0.03%	605

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Trexquant Investment's RYTM Position: Q2 2026 in Review

Trexquant Investment opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 56,248 shares worth $6.25M. The stake represents 0.04% of the portfolio and ranks #629 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in RYTM as recently as Q3 2025.

Trexquant Investment first reported a position in RYTM in Q2 2018 and has held it in 8 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Trexquant Investment held 56,248 shares of Rhythm Pharmaceuticals worth $6.25M as of Q2 2026.
Rhythm Pharmaceuticals was a new Trexquant Investment position in Q2 2026.
Rhythm Pharmaceuticals made up 0.04% of Trexquant Investment's portfolio in Q2 2026, its #629 holding.
Trexquant Investment first reported a position in Rhythm Pharmaceuticals in Q2 2018 and has held it in 8 quarters since.
304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.